These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 14983620)

  • 1. The cost of drugs: a policy conundrum of global proportions.
    Barry DR; Romig B
    N C Med J; 2003; 64(6):287-8. PubMed ID: 14983620
    [No Abstract]   [Full Text] [Related]  

  • 2. Border crossing.
    Fuller C
    Revolution (Oakl); 2003; 4(5):24-9. PubMed ID: 14631721
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives. Health person of the year.
    Med Health; 2004 Jan; 58(1):1, 7-8. PubMed ID: 14743598
    [No Abstract]   [Full Text] [Related]  

  • 4. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 5. The new drug war.
    Parloff R
    Fortune; 2004 Mar; 149(5):144-6, 148, 150 passim. PubMed ID: 15015428
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 7. The nature and consequences of policies intended to contain costs in outpatient drug insurance programs.
    Reutzel TJ
    Clin Ther; 1993; 15(4):752-64. PubMed ID: 8221825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the impact of reference-based pricing.
    Grootendorst P; Holbrook A
    CMAJ; 1999 Aug; 161(3):273-4. PubMed ID: 10463048
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
    Work DR; Domino ME
    N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
    [No Abstract]   [Full Text] [Related]  

  • 10. To cut costs, risky drug use.
    Consum Rep; 2011 Nov; 76(11):9. PubMed ID: 22022754
    [No Abstract]   [Full Text] [Related]  

  • 11. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising drug costs: the impact on dermatology.
    Rico MJ
    Skin Therapy Lett; 2000; 5(4):1-2,5. PubMed ID: 10785406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access, cost and quality.
    Stearns C
    J Fla Med Assoc; 1993 Jun; 80(6):423-5. PubMed ID: 8340782
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinton team works with drug companies to expand access, restrict costs.
    Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
    [No Abstract]   [Full Text] [Related]  

  • 15. Saving money on your prescription drugs.
    Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):4-5. PubMed ID: 20336846
    [No Abstract]   [Full Text] [Related]  

  • 16. Do drug copayments work?
    David J
    CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
    [No Abstract]   [Full Text] [Related]  

  • 17. The health care conundrum: providing access to the uninsured while balancing costs.
    Logan DC; Mokrohisky C
    WMJ; 2005 Nov; 104(8):50-1. PubMed ID: 16425921
    [No Abstract]   [Full Text] [Related]  

  • 18. Essential health care: affordable for all?
    Mundinger MO; Thomas E; Smolowitz J; Honig J
    Nurs Econ; 2004; 22(5):239-44, 227. PubMed ID: 15586477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical companies meet the needs of the poor and uninsured: an important element in the healthcare safety net.
    Hartsfield JA
    N C Med J; 2005; 66(2):144-6. PubMed ID: 15952468
    [No Abstract]   [Full Text] [Related]  

  • 20. Health care in the 21st century.
    Harris RM
    N Engl J Med; 2005 May; 352(18):1927-8. PubMed ID: 15877322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.